This site is part of the Siconnects Division of Sciinov Group
This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.
ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR
Sciinov Group is proud to announce the Oligonucleotide Therapeutics and Delivery Conference, 23-24 March, 2026 in Rome, Italy. This year OTDC 2026 annual Oligonucleotide Therapeutics and Delivery conference will showcase recent advances in oligonucleotide development, regulatory requirements and CMC considerations, strategies to enhance oligonucleotide discovery and targeting and optimised delivery techniques for oligonucleotide-based therapies, in the hope to continue to drive forward the field of oligonucleotide drug development. Join us on the 23 March, 2026 at Rome, Italy.
Industry and academic experts deliver detailed case studies on antisense, RNA, GalNAc, aptamers, conju...
We are always looking for new industry leaders to join our speaker faculty to deliver presentations, lead panel discussions and moderate sessions or roundtables.
If you are interested in being considered as a speaker, submit your proposal/abstract Online
We let speakers propose the topic they want to talk about. This process allows speakers to propose sessions that speak from their expertise and passion.
Speaker can choose the topic of your choice in related to the conference subject or any of their recent research work to present at our conference.
For details of scientific sessions covered please visit [not limited to, you can propose]
Please visit the page here
Yes, as our conference is scheduled in Hybrid Mode, you can present and listen to full program virtually connecting via ZOOM live stream
04 Apr
2025
A cellular regulator of mRNA vaccines has been discovered, opening up new therapeutic possibilities
Dr. Kim V. Narry's team at the Institute for Basic Science has revealed a key cellular mechanism affecting mRNA vaccine function, offering insights to improve RNA-based treatments.Readmore
09 Apr
2025
Engineering Efficient Delivery Methods for Gene Editing
A team from Helmholtz Munich and the Technical University of Munich has developed ENVLPE, an advanced delivery system that uses engineered virus-like particles to efficiently transport CRISPR/Cas9 gene-editing tools into cells.Readmore
09 Apr
2025
Ractigen's RAG-17 ALS Data Impresses at AAN 2025: Wins Top Award, Phase I Progresses
Ractigen Therapeutics announced that the final positive results from the Investigator-Initiated Trial (IIT) of RAG-17, a siRNA therapy for ALS targeting SOD1, were presented for the first time at the AAN 2025 Annual Meeting in San Diego. Readmore
09 Apr
2025
New Gene Editing Tool Shows Promise for Treating Diseases with Multiple Mutations
Scientists at Mass General Brigham and Beth Israel have developed STITCHR, an RNA-only gene editing tool that inserts full genes precisely without unwanted mutations. Readmore
.jpg.jpg)
Thank you very much for the organization of such an event. I have learned a lot.
Congratulations on the great turnout at the Aging and Gerontology Conference this year!!! I really enjoyed presenting at your event
It was a great experience exchanging views on Aging with speakers from all around the world.
Good day a very nice and informative congress, most of the presentations were very interesting. As a clinical medical doctor i hope some of them can help me in my daily private practice and institutional one. Besides congratulate you for the quality of the Keynote and oral presentations.
Global
By Product (Oligonucleotide-Based Drugs, Synthesized Oligonucleotides, Reagents, and Equipment), Application (Therapeutic Applications, Research Applications, and Diagnostic Applications) and End User (Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, CROs and CMOs, Academic Research Institutes)
Global
Market by Type (Synthetic APIs, Natural APIs), by Product Type (Custom Oligonucleotide APIs, Purified Oligonucleotide APIs), by Application (Therapeutic Application, Diagnostic Application) and by End User (Research Laboratories, Academic Institutes, Pharmaceutical Companies)
Global
Report by Products Services (Reagents Kits, Genotyping Services, Bioinformatics Software, Instruments), by Technology (Microarrays, Capillary Electrophoresis, Polymerase Chain Reaction (PCR), Sequencing, MALDI-TOF, Allele Specific Oligonucleotide (ASO) Probes, Others), by Applications (Pharmacogenomics, Animal Genetics, Diagnostic Research, Agricultural Biotechnology, Others) and by End User (Pharmaceutical Biopharmaceutical Companies, Diagnostic Research Laboratories, Academic Institutes)
Global
By Types (Oligonucleotide Synthesis, Gene Synthesis) and by Applications (Hospital, Clinics, Biotech Company, Others)
Global
Market by Product (Enabling Products, DNA Synthesis, Oligonucleotide Synthesis, Enabled Products, Pharmaceuticals, Chemical, Biofuels, Agriculture, Core Products, Synthetic DNA, Synthetic Genes, Synthetic Cells, XNA, Chassis Organisms), by Technology (Enabling Technology, Genome Engineering, Microfluidics technologies, DNA synthesis sequencing technologies, Bioinformatics technologies, Biological components and integrated systems technologies, Enabled Technology, Pathway engineering, Synthetic microbial consortia, Biofuels technologies), by Application (Research Development, Chemicals, Agriculture, Pharmaceuticals Diagnostics, Biofuels, Environment, Biotechnology, Biomaterials, Others) and by End User (Hospitals, Clinics, Others)
.jpeg.jpeg)
.jpeg.jpeg)
